FDA shifts on rare-disease drug approval
Monday, July 17, 2017 - 00:12
in Health & Medicine
Amicus Therapeutics needn’t conduct a new trial for Fabry disease treatment, agency says
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via